HBV genotypes: Relevance to natural history, pathogenesis and treatment of chronic hepatitis B

Beom Kyung Kim, Peter A. Revill, Sang Hoon Ahn

Research output: Contribution to journalReview article

96 Citations (Scopus)

Abstract

Although chronic HBV infection is the leading cause of chronic liver disease and death worldwide, there are substantial differences in its clinical courses regarding prevalence, mode of transmission, characteristics of each phase, responses to antiviral therapy, and development of cirrhosis and hepatocellular carcinoma, according to geographical areas (Asia versus Western Europe and North America versus Africa). Furthermore, the clinical course in infected individuals depends on a complex interplay among various factors including viral, host, environmental and other factors. Recently, understanding of molecular characteristics of the prevailing HBV genotypes, frequently accompanied mutations and their clinical implications might explain these geographical differences more pertinently. Hence, in this article, we review the global epidemiology and the natural history of HBV infection, with emphasis on summarizing the different HBV genotypes according to regions.

Original languageEnglish
Pages (from-to)1169-1186
Number of pages18
JournalAntiviral therapy
Volume16
Issue number8
DOIs
Publication statusPublished - 2011 Dec 19

Fingerprint

Chronic Hepatitis B
Natural History
Genotype
North America
Infection
Antiviral Agents
Liver Diseases
Hepatocellular Carcinoma
Epidemiology
Fibrosis
Chronic Disease
Mutation
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

@article{af51dc85b10f42a4b18c39b3a407c4fe,
title = "HBV genotypes: Relevance to natural history, pathogenesis and treatment of chronic hepatitis B",
abstract = "Although chronic HBV infection is the leading cause of chronic liver disease and death worldwide, there are substantial differences in its clinical courses regarding prevalence, mode of transmission, characteristics of each phase, responses to antiviral therapy, and development of cirrhosis and hepatocellular carcinoma, according to geographical areas (Asia versus Western Europe and North America versus Africa). Furthermore, the clinical course in infected individuals depends on a complex interplay among various factors including viral, host, environmental and other factors. Recently, understanding of molecular characteristics of the prevailing HBV genotypes, frequently accompanied mutations and their clinical implications might explain these geographical differences more pertinently. Hence, in this article, we review the global epidemiology and the natural history of HBV infection, with emphasis on summarizing the different HBV genotypes according to regions.",
author = "Kim, {Beom Kyung} and Revill, {Peter A.} and Ahn, {Sang Hoon}",
year = "2011",
month = "12",
day = "19",
doi = "10.3851/IMP1982",
language = "English",
volume = "16",
pages = "1169--1186",
journal = "Antiviral Therapy",
issn = "1359-6535",
publisher = "International Medical Press Ltd",
number = "8",

}

HBV genotypes : Relevance to natural history, pathogenesis and treatment of chronic hepatitis B. / Kim, Beom Kyung; Revill, Peter A.; Ahn, Sang Hoon.

In: Antiviral therapy, Vol. 16, No. 8, 19.12.2011, p. 1169-1186.

Research output: Contribution to journalReview article

TY - JOUR

T1 - HBV genotypes

T2 - Relevance to natural history, pathogenesis and treatment of chronic hepatitis B

AU - Kim, Beom Kyung

AU - Revill, Peter A.

AU - Ahn, Sang Hoon

PY - 2011/12/19

Y1 - 2011/12/19

N2 - Although chronic HBV infection is the leading cause of chronic liver disease and death worldwide, there are substantial differences in its clinical courses regarding prevalence, mode of transmission, characteristics of each phase, responses to antiviral therapy, and development of cirrhosis and hepatocellular carcinoma, according to geographical areas (Asia versus Western Europe and North America versus Africa). Furthermore, the clinical course in infected individuals depends on a complex interplay among various factors including viral, host, environmental and other factors. Recently, understanding of molecular characteristics of the prevailing HBV genotypes, frequently accompanied mutations and their clinical implications might explain these geographical differences more pertinently. Hence, in this article, we review the global epidemiology and the natural history of HBV infection, with emphasis on summarizing the different HBV genotypes according to regions.

AB - Although chronic HBV infection is the leading cause of chronic liver disease and death worldwide, there are substantial differences in its clinical courses regarding prevalence, mode of transmission, characteristics of each phase, responses to antiviral therapy, and development of cirrhosis and hepatocellular carcinoma, according to geographical areas (Asia versus Western Europe and North America versus Africa). Furthermore, the clinical course in infected individuals depends on a complex interplay among various factors including viral, host, environmental and other factors. Recently, understanding of molecular characteristics of the prevailing HBV genotypes, frequently accompanied mutations and their clinical implications might explain these geographical differences more pertinently. Hence, in this article, we review the global epidemiology and the natural history of HBV infection, with emphasis on summarizing the different HBV genotypes according to regions.

UR - http://www.scopus.com/inward/record.url?scp=83455179343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83455179343&partnerID=8YFLogxK

U2 - 10.3851/IMP1982

DO - 10.3851/IMP1982

M3 - Review article

C2 - 22155900

AN - SCOPUS:83455179343

VL - 16

SP - 1169

EP - 1186

JO - Antiviral Therapy

JF - Antiviral Therapy

SN - 1359-6535

IS - 8

ER -